Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00002067 | A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia | PHASE3 | COMPLETED | - | — | — | - | - | Oct 2, 2007 | 14 | United States |
| NCT00002300 | A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition | PHASE2 | COMPLETED | - | — | — | - | - | Oct 2, 2007 | 15 | United States |
| Name | Type | Description |
|---|---|---|
| Megestrol acetate | DRUG | - |
Inclusion Criteria Patient must have: * Confirmed diagnosis of AIDS (CDC definition). * Documented weight loss or anorexia. * Life expectancy = or \> 20 weeks. * The perception that the weight loss is a detriment to their well-being. * Ability to provide informed consent, read and write English. ...